These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2693025)

  • 1. [Phase II clinical trial on mitoxantrone].
    Gao HR
    Zhonghua Zhong Liu Za Zhi; 1989 May; 11(3):204-6. PubMed ID: 2693025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitoxantrone in the treatment of patients with non-Hodgkin's Lymphoma.
    Foss-Abrahamsen A; Lenner P; Hedenus M; Landys K; Noppa H
    Cancer Treat Rep; 1987 Dec; 71(12):1209-12. PubMed ID: 3690531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mitoxantrone containing multi-drug chemotherapy in the management of malignancies. Collaborative Group for Clinical Trial of Mitoxantrone].
    Zhonghua Zhong Liu Za Zhi; 1989 Jul; 11(4):300-3. PubMed ID: 2696630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitoxantrone: an active agent in refractory non-Hodgkin's lymphomas.
    Bajetta E; Buzzoni R; Valagussa P; Bonadonna G
    Am J Clin Oncol; 1988 Apr; 11(2):100-3. PubMed ID: 3282421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitoxantrone as single agent in the treatment of advanced breast cancer: clinical experience at Siriraj Hospital.
    Tepmongkol P; Suphaphongs N; Thansakul A; Jirapanuwat S; Skulchan V; Rojananin S; Chantarakul N
    J Med Assoc Thai; 1989 Feb; 72(2):82-9. PubMed ID: 2738491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Phase II trial of mitoxantrone in patients with relapsed and refractory acute leukemia].
    Sampi K; Ogawa M; Kimura I; Ohnoshi T; Yamada K; Masaoka T; Wakui A; Meguro S; Nagai K; Kitani T
    Gan To Kagaku Ryoho; 1986 Oct; 13(10):3021-7. PubMed ID: 3464230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of mitoxantrone in epithelial ovarian cancer.
    Lawton F; Blackledge G; Mould J; Latief T; Watson R; Chetiyawardana AD
    Cancer Treat Rep; 1987 Jun; 71(6):627-9. PubMed ID: 3581101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose mitoxantrone in metastatic breast cancer: a phase I-II trial.
    Leiby JM; Unverfurth DV; Neidhart JA
    Cancer Treat Rep; 1986 Jul; 70(7):899-901. PubMed ID: 3719583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Phase II study of mitoxantrone for hematologic malignancies].
    Ueoka H; Ueno K; Yamane T; Toyoda K; Endo H; Nishihara R; Takahashi I; Ohnoshi T; Kitajima K; Kimura I
    Gan To Kagaku Ryoho; 1983 Nov; 10(11):2399-402. PubMed ID: 6639101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitoxantrone in elderly women with advanced breast cancer: a phase II study.
    Repetto L; Simoni C; Venturino A; Biancardi V; Gasco M; Campora E; Rosso R
    Anticancer Res; 1995; 15(5B):2297-300. PubMed ID: 8572641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A phase II study of mitoxantrone in refractory and relapsed malignant lymphomas. Cooperative Study Group of Mitoxantrone in Malignant Lymphomas].
    Kimura I; Ohnoshi T; Ogawa M; Sampi K; Masaoka T; Yamada K; Ohta K; Kitani T; Kawagoe H; Shirakawa S
    Gan To Kagaku Ryoho; 1986 Sep; 13(9):2800-6. PubMed ID: 3753026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Phase II study of mitoxantrone in advanced breast cancer].
    Ogawa M; Kubo K; Tominaga T; Nomura Y; Ota K; Yoshida M; Taguchi T; Hoshino A
    Gan To Kagaku Ryoho; 1986 May; 13(5):1980-4. PubMed ID: 3707156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitoxantrone: a novel anthracycline derivative.
    Koeller J; Eble M
    Clin Pharm; 1988 Aug; 7(8):574-81. PubMed ID: 3048848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I clinical and pharmacokinetic study of mitoxantrone given to patients by intraperitoneal administration.
    Alberts DS; Surwit EA; Peng YM; McCloskey T; Rivest R; Graham V; McDonald L; Roe D
    Cancer Res; 1988 Oct; 48(20):5874-7. PubMed ID: 3167842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Phase II trial of mitoxantrone in patients with relapsed and refractory acute leukemia].
    Sampi K; Kaneko Y; Maseki N; Kumai R; Sakurai M; Hattori M
    Gan To Kagaku Ryoho; 1985 Jul; 12(7):1453-7. PubMed ID: 4015120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Phase I trial of 4'-O-tetrahydropyranyl-doxorubicin (THP)--a multi-institutional cooperative study].
    Wakui A; Yokoyama M; Konno K; Nakai Y; Sakano T; Koyama Y; Imamura Y; Nakajima O; Niijima T; Akaza H
    Gan To Kagaku Ryoho; 1985 Jan; 12(1):118-24. PubMed ID: 3966806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitoxantrone: modest activity in a phase II trial in advanced prostate cancer.
    Osborne CK; Drelichman A; Von Hoff DD; Crawford ED
    Cancer Treat Rep; 1983 Dec; 67(12):1133-5. PubMed ID: 6652630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitoxantrone, 5-fluorouracil and cyclophosphamide in advanced breast cancer.
    Martoni A; Rani P; Ercolino L; Canova N; Pannuti F
    Chemioterapia; 1988 Oct; 7(5):345-9. PubMed ID: 3224403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Phase II study of mitoxantrone].
    Tada A; Ogawa M; Usui N; Inagaki J; Horikoshi N; Inoue K; Ikeda K; Adachi K; Nakada H; Okada Y
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1649-54. PubMed ID: 6476838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Phase II study of mitoxantrone in patients with acute leukemia].
    Kimura K; Yoshikawa S; Yoshikawa H; Yamada K; Hirano M; Ikeda Y; Ohta K; Ohara K; Kobayashi M; Shirakawa S
    Gan To Kagaku Ryoho; 1986 Aug; 13(8):2573-80. PubMed ID: 3740858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.